Sarah B. Noonberg
Board Member
Neurogene Inc. (NGNE)Equibles does not estimate personal net worth.
Get an email with a short summary when Neurogene Inc. publishes a filing, an earnings call transcript or a press release.
Get NGNE alertsAbout Sarah B. Noonberg
Sarah B. Noonberg is recorded as Board Member at Neurogene Inc. (NGNE) since January 1, 2019. The newest filing on record that lists Sarah B. Noonberg as Board Member at Neurogene Inc. (NGNE) is dated April 16, 2026. Neurogene Inc. reported in an 8-K filed June 12, 2025 that Sarah B. Noonberg was appointed Class II director, effective June 12, 2025. Neurogene Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Neurogene Inc. includes David J. Main (CEO), Donna M. Cochener (CEO), Rachel McMinn (CEO, Chairman and Board Member) and 7 others.
“Election of two Class II directors, Sarah B. Noonberg and Robert “Keith” Woods, each to serve until the 2028 annual meeting of stockholders and until their respective successors are elected and qualified”
Affiliation history
-
Current
2019-01-01–present
Last confirmed April 16, 2026
Company network
Leadership on record at Neurogene Inc.
- David J. Main CEO
- Donna M. Cochener CEO
- Rachel McMinn CEO, Chairman, Board Member
- Christine Mikail CFO, Board Member
- Christine Mikail Cvijic CFO
- Jonathan Drachman CFO
- Robert Ho CFO
- Sean Smith CFO, Chief Accounting Officer
- Donna Cochener General Counsel
- Cory Freedland Board Member